The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
Official Title: INTENT Pilot Study - Enhancing Adherence Intentions to Endocrine Therapy
Study ID: NCT06246084
Brief Summary: This research is being done to pilot an intervention which aims to improve participants' experiences on Endocrine Therapy. The name of the intervention used in this research study is: Endocrine Therapy Education Program (a brief, video-based intervention)
Detailed Description: This research study is a randomized pilot study to determine whether a brief-video based intervention program can improve experiences of Endocrine Therapy (ET). Participants will be randomized into one of two groups: Group A: Endocrine Therapy Education Intervention vs. Group B Wait-list Control Group. Randomization means a participant is placed into a study group by chance. The research study procedures include screening for eligibility, in-clinic visits, and survey questionnaires. Participation in this research study is expected to last 3 months. It is expected that about 60 people will take part in this research study.
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Name: Ann Partridge, MD, MPH
Affiliation: Dana-Farber Cancer Institute
Role: PRINCIPAL_INVESTIGATOR